ADA 2025 20 - 23 June 2025

Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes: The STEP UP T2D Trial

Authors :

Ildiko Lingvay¹; Sara J Bergenheim²; John Buse³; Paula Freitas^4,5; W. Timothy Garvey⁶; Nina M. Harder-Lauridsen²; Julio Rosenstock⁷; Kushal Sahu²; Sean Wharton^8,9

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Efficacy and Safety of Semaglutide 7.2 mg in Obesity and Type 2 Diabetes: The STEP UP T2D Trial